193 related articles for article (PubMed ID: 36883571)
1. International symposium on pheochromocytoma: an event of dedicated healthcare professionals and researchers striving for better patient outcomes.
Pacak K; Clifton-Bligh R
Endocr Relat Cancer; 2023 May; 30(5):. PubMed ID: 36883571
[TBL] [Abstract][Full Text] [Related]
2. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
[TBL] [Abstract][Full Text] [Related]
3. Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Genetics, and Therapeutic Approaches.
Kuo MJM; Nazari MA; Jha A; Pacak K
Front Endocrinol (Lausanne); 2022; 13():936178. PubMed ID: 35903274
[TBL] [Abstract][Full Text] [Related]
4. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.
Lenders JW; Duh QY; Eisenhofer G; Gimenez-Roqueplo AP; Grebe SK; Murad MH; Naruse M; Pacak K; Young WF;
J Clin Endocrinol Metab; 2014 Jun; 99(6):1915-42. PubMed ID: 24893135
[TBL] [Abstract][Full Text] [Related]
5. PHEOCHROMOCYTOMA: A GENETIC AND DIAGNOSTIC UPDATE.
Mercado-Asis LB; Wolf KI; Jochmanova I; Taïeb D
Endocr Pract; 2018 Jan; 24(1):78-90. PubMed ID: 29144820
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the management of pheochromocytoma and paraganglioma.
Tanabe A; Naruse M
Hypertens Res; 2020 Nov; 43(11):1141-1151. PubMed ID: 32778780
[TBL] [Abstract][Full Text] [Related]
7. Pheochromocytomas and paragangliomas.
Yen K; Lodish M
Curr Opin Pediatr; 2021 Aug; 33(4):430-435. PubMed ID: 34039901
[TBL] [Abstract][Full Text] [Related]
8. The Pheochromocytoma/Paraganglioma syndrome: an overview on mechanisms, diagnosis and management.
Lima JV; Kater CE
Int Braz J Urol; 2023; 49(3):307-319. PubMed ID: 37115176
[TBL] [Abstract][Full Text] [Related]
9. Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma.
Eisenhofer G; Deutschbein T; Constantinescu G; Langton K; Pamporaki C; Calsina B; Monteagudo M; Peitzsch M; Fliedner S; Timmers HJLM; Bechmann N; Fankhauser M; Nölting S; Beuschlein F; Stell A; Fassnacht M; Prejbisz A; Lenders JWM; Robledo M
Clin Chem Lab Med; 2020 Oct; 59(2):353-363. PubMed ID: 33001846
[TBL] [Abstract][Full Text] [Related]
10. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
Rao D; Peitzsch M; Prejbisz A; Hanus K; Fassnacht M; Beuschlein F; Brugger C; Fliedner S; Langton K; Pamporaki C; Gudziol V; Stell A; Januszewicz A; Timmers HJLM; Lenders JWM; Eisenhofer G
Eur J Endocrinol; 2017 Aug; 177(2):103-113. PubMed ID: 28476870
[TBL] [Abstract][Full Text] [Related]
11. Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management.
Jain A; Baracco R; Kapur G
Pediatr Nephrol; 2020 Apr; 35(4):581-594. PubMed ID: 30603807
[TBL] [Abstract][Full Text] [Related]
12. Pheochromocytomas and Hypertension.
Pappachan JM; Tun NN; Arunagirinathan G; Sodi R; Hanna FWF
Curr Hypertens Rep; 2018 Jan; 20(1):3. PubMed ID: 29356966
[TBL] [Abstract][Full Text] [Related]
13. Molecular imaging and theranostic approaches in pheochromocytoma and paraganglioma.
Taïeb D; Pacak K
Cell Tissue Res; 2018 May; 372(2):393-401. PubMed ID: 29450723
[TBL] [Abstract][Full Text] [Related]
14. Congenital Cyanotic Heart Disease and the Association with Pheochromocytomas and Paragangliomas.
Jones RB; Cohen DL
Curr Cardiol Rep; 2023 Nov; 25(11):1451-1460. PubMed ID: 37847359
[TBL] [Abstract][Full Text] [Related]
15. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.
Garcia-Carbonero R; Matute Teresa F; Mercader-Cidoncha E; Mitjavila-Casanovas M; Robledo M; Tena I; Alvarez-Escola C; Arístegui M; Bella-Cueto MR; Ferrer-Albiach C; Hanzu FA
Clin Transl Oncol; 2021 Oct; 23(10):1995-2019. PubMed ID: 33959901
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force.
Ku EJ; Kim KJ; Kim JH; Kim MK; Ahn CH; Lee KA; Lee SH; Lee YB; Park KH; Choi YM; Hong N; Hong AR; Kang SW; Park BK; Seong MW; Kim M; Jung KC; Jung CK; Cho YS; Paeng JC; Kim JH; Ryu OH; Rhee Y; Kim CH; Lee EJ
Endocrinol Metab (Seoul); 2021 Apr; 36(2):322-338. PubMed ID: 33820394
[TBL] [Abstract][Full Text] [Related]
17. Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or Pheochromocytoma.
Buffet A; Ben Aim L; Leboulleux S; Drui D; Vezzosi D; Libé R; Ajzenberg C; Bernardeschi D; Cariou B; Chabolle F; Chabre O; Darrouzet V; Delemer B; Desailloud R; Goichot B; Esvant A; Offredo L; Herman P; Laboureau S; Lefebvre H; Pierre P; Raingeard I; Reznik Y; Sadoul JL; Hadoux J; Tabarin A; Tauveron I; Zenaty D; Favier J; Bertherat J; Baudin E; Amar L; Gimenez-Roqueplo AP;
J Clin Endocrinol Metab; 2019 Apr; 104(4):1109-1118. PubMed ID: 30698717
[TBL] [Abstract][Full Text] [Related]
18. From Diagnosis to Therapy-PET Imaging for Pheochromocytomas and Paragangliomas.
Patel HV; Srivastava A; Becker MD; Beninato T; Laird AM; Singer EA
Curr Urol Rep; 2021 Jan; 22(1):2. PubMed ID: 33403502
[TBL] [Abstract][Full Text] [Related]
19. Genetics, diagnosis, and management of medullary thyroid carcinoma and pheochromocytoma/paraganglioma.
Moraitis AG; Martucci VL; Pacak K
Endocr Pract; 2014 Feb; 20(2):176-87. PubMed ID: 24449662
[TBL] [Abstract][Full Text] [Related]
20. Laboratory evaluation of pheochromocytoma and paraganglioma.
Eisenhofer G; Peitzsch M
Clin Chem; 2014 Dec; 60(12):1486-99. PubMed ID: 25332315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]